These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4981466)

  • 1. Separation of SK-plasminogen-complex in sera and euglobulin solution of cat and monkey by gel filtration using sephadex G-200.
    Nitta H; Sugie I; Ikai M; Ozio M; Takahashi N
    Nagoya Med J; 1969 Jul; 15(2):93-102. PubMed ID: 4981466
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the interaction between streptokinase and fibrinolytic precursor in human blood applying gel filtration.
    Sugie I; Ikai M; Ozio M; Nitta H
    Nagoya Med J; 1969 Jul; 15(2):103-12. PubMed ID: 4242215
    [No Abstract]   [Full Text] [Related]  

  • 3. Separation of the fibrinolytic substances in euglobulin solution of man and dog plasma by gel filtration using Sephadex G-100 and 200.
    Nitta H; Sugie I; Sato S; Morimoto S; Miyachi S
    Nagoya Med J; 1967 Mar; 13(1):23-32. PubMed ID: 6075636
    [No Abstract]   [Full Text] [Related]  

  • 4. Activation of thrombolysis by streptokinase in the cat.
    Fleming LB; Cliffton EE
    Am J Physiol; 1965 Sep; 209(3):584-92. PubMed ID: 4220898
    [No Abstract]   [Full Text] [Related]  

  • 5. A new method based on one dimensional diffusion using small glass tubes for the measurement of fibrinolytic activity. I. Fibrinolytic activity of plasmin and "euglobulin + streptokinase".
    Yasukouchi T; Watanabe T
    Thromb Diath Haemorrh; 1972 Dec; 28(3):329-41. PubMed ID: 4265315
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetic properties of the activator complexes plasmin--staphylokinase and plasmin(ogen)--streptokinase in vitro.
    Sazonova IY; Aisina RB; Muhametova LI; Varfolomeyev SD
    Biochemistry (Mosc); 1999 Jan; 64(1):66-74. PubMed ID: 9986915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation and characterization of two fibrinolytic inhibitors from human placenta.
    Uszynski M; Abildgaard U
    Thromb Diath Haemorrh; 1971 Jun; 25(3):580-9. PubMed ID: 4998018
    [No Abstract]   [Full Text] [Related]  

  • 8. [The technique of quantitative determination of streptokinase in the patient's plasma (author's transl)].
    Auel H; Martin M
    Klin Wochenschr; 1975 Sep; 53(17):809-14. PubMed ID: 811926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gel filtration studies of the complex forming capacity of streptokinase with human and heterologous plasminogens.
    Doleschel W; Auerswald W
    Med Pharmacol Exp Int J Exp Med; 1967; 17(3):248-54. PubMed ID: 4967532
    [No Abstract]   [Full Text] [Related]  

  • 10. [A method for separation of plasminogen from bovine plasma fraction. I. With reference to some properties of the plasminogen].
    Okamoto U; Matumoto M
    Nihon Seirigaku Zasshi; 1971; 33(7):394-402. PubMed ID: 4255047
    [No Abstract]   [Full Text] [Related]  

  • 11. The amidolytic activity of the SK-plasminogen complex is enhanced by a potentiator which is generated in the presence of vascular plasminogen activator--role of fibrin degradation products.
    Soria J; Soria C; Bertrand O; Dunn F; Samama M; Bachmann F
    Thromb Haemost; 1982 Jun; 47(3):193-6. PubMed ID: 7051407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thrombolytic activity of streptokinase in the rabbit.
    English PD; Smith RA; Dupe RJ; Green J; Hibbs MJ
    Thromb Haemost; 1981 Aug; 46(2):535-7. PubMed ID: 7302893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of anti-streptokinase antibody levels in human sera using a microradioimmunoassay procedure.
    Moran DM; Standring R; Lavender EA; Harris GS
    Thromb Haemost; 1984 Dec; 52(3):281-7. PubMed ID: 6531752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
    Poredos P; Videcnik V
    Wien Klin Wochenschr; 1999 Jan; 111(1):21-5. PubMed ID: 10067266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Difference between serum and euglobulin in the determination of fibrinolytic activity by SK-method; evaluation of determination methods for the fibrinolytic activity].
    Miyatani K; Fukui I
    Rinsho Byori; 1970 Jun; 18(6):447-50. PubMed ID: 5466023
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasminogen-fibrinogen complex formation as a prelude to fibrinogenolysis. A density-gradient ultracentrifugation study of radioiodinated systems involving urokinase, plasminogen, and fibrinogen.
    Ball AP; Silver D; Day ED
    Thromb Diath Haemorrh; 1971; 25(1):114-28. PubMed ID: 5103731
    [No Abstract]   [Full Text] [Related]  

  • 17. Betalipoproteins and euglobulin lysis time.
    Cucuianu M
    Thromb Diath Haemorrh; 1966 Dec; 16(3):687-96. PubMed ID: 5996681
    [No Abstract]   [Full Text] [Related]  

  • 18. Mapping of the plasminogen binding site of streptokinase with short synthetic peptides.
    Nihalani D; Raghava GP; Sahni G
    Protein Sci; 1997 Jun; 6(6):1284-92. PubMed ID: 9194188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on plasminogen. 8. Species specificity of streptokinase.
    Wulf RJ; Mertz ET
    Can J Biochem; 1969 Oct; 47(10):927-31. PubMed ID: 4981635
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the ratio of the euglobulin clot lysis time and fibrinogen content in euglobulin (author's transl)].
    Matsuo T; Matsunaga K
    Rinsho Ketsueki; 1974 Oct; 15(10):1128-32. PubMed ID: 4476809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.